Biocryst Pharmaceuticals (BCRX) Selling, General & Administrative (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Selling, General & Administrative of $63.98 million for Q2 2026, down 26.8% from $87.38 million a year earlier and down 32.3% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Biocryst Pharmaceuticals was $337.33 million, up 6.9% year-over-year; for FY2025, it came in at $348.65 million, up 30.9% from FY2024.
- Annual Selling, General & Administrative has increased for nine consecutive years, with a five-year compound annual growth rate of 38.7% (FY2020 to FY2025).
- In prior years, Biocryst Pharmaceuticals' Selling, General & Administrative was $266.35 million in FY2024 (+24.4%), $214.07 million in FY2023 (+34.3%), $159.37 million in FY2022 (+34.1%) and $118.82 million in FY2021 (+74.9%).
- The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q2 2024.
- On a year-over-year basis, Selling, General & Administrative increased in seven of the last eight quarters, with growth averaging 21.1%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 103.5%; the weakest was Q2 2026, with a decline of 26.8%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $94.55 million (Q1 2026), $95.78 million (Q4 2025) and $83.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Biocryst Pharmaceuticals | 2.09 Bn | 1.01 Bn | 214.41 Mn | 63.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.98 Mn |
| Mar 31, 2026 | 94.55 Mn |
| Dec 31, 2025 | 95.78 Mn |
| Sep 30, 2025 | 83.01 Mn |
| Jun 30, 2025 | 87.38 Mn |
| Mar 31, 2025 | 82.47 Mn |
| Dec 31, 2024 | 80.51 Mn |
| Sep 30, 2024 | 65.10 Mn |
| Jun 30, 2024 | 61.25 Mn |
| Mar 31, 2024 | 59.49 Mn |
| Dec 31, 2023 | 64.56 Mn |
| Sep 30, 2023 | 50.65 Mn |
| Jun 30, 2023 | 51.00 Mn |
| Mar 31, 2023 | 47.87 Mn |
| Dec 31, 2022 | 50.15 Mn |
| Sep 30, 2022 | 36.92 Mn |
| Jun 30, 2022 | 38.02 Mn |
| Mar 31, 2022 | 34.28 Mn |
| Dec 31, 2021 | 35.39 Mn |
| Sep 30, 2021 | 34.99 Mn |
API Access
Biocryst Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();